The focus of the “2014 AHA/ACC Guideline for the Management of Patients With Valvular
Heart Disease” 9, 10 (2014 VHD guideline) was the diagnosis and management of adult …

The incidence of pregnancy in women with cardiovascular disease is rising, primarily due to
the increased number of women with congenital heart disease reaching childbearing age …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

The “Guidelines on the Management of Valvular Heart Disease” were initially published as
the “Guidelines on Non-pharmacological Treatment of Valvular Heart Disease” in 2002 …

A doença cardíaca isquêmica, principal determinante da PCR, continua liderando as
causas de morte no mundo, e no Brasil não é diferente. 1, 2 Em 2013, nos Estados Unidos …

not override in any way whatsoever the individual responsibility of health professionals to
make appropriate and accurate decisions in consideration of each patient's health condition …

Background Low-dose (25 mg), slow infusion (6 hours) of tissue-type plasminogen activator
(t-PA) with repetition as needed has been shown to provide effective and safer thrombolysis …

Background Prosthetic valve thrombosis (PVT) is one of the life-threatening complications of
prosthetic heart valve replacement. Due to the lack of randomized controlled trials, the …

Cardiovascular disease complicates% 1% to 3% of all pregnancies and is responsible for
10% to 15% of maternal mortality. Although its prevalence is considered relatively low in …